modafinil has been researched along with Atherosclerotic Parkinsonism in 1 studies
Modafinil: A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.
modafinil : A racemate comprising equimolar amounts of armodafinil and (S)-modafinil. A central nervous system stimulant, it is used for the treatment of sleeping disorders such as narcolepsy, obstructive sleep apnoea, and shift-work sleep disorder. The optical enantiomers of modafinil have similar pharmacological actions in animals.
2-[(diphenylmethyl)sulfinyl]acetamide : A sulfoxide that is dimethylsulfoxide in which two hydrogens attached to one of the methyl groups are replaced by phenyl groups, while one hydrogen attached to the other methyl group is replaced by a carbamoyl (aminocarbonyl) group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cepeda, MS | 1 |
| Kern, DM | 1 |
| Seabrook, GR | 1 |
| Lovestone, S | 1 |
1 trial available for modafinil and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Comprehensive Real-World Assessment of Marketed Medications to Guide Parkinson's Drug Discovery.
Topics: Adrenergic beta-Antagonists; Adult; Antiparkinson Agents; Cohort Studies; Databases, Factual; Drug D | 2019 |